Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0382 | 0.2286 | 0.426 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Echinococcus multilocularis | 0.1079 | 0.7714 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0382 | 0.2286 | 0.426 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0382 | 0.2286 | 0.426 |
Echinococcus multilocularis | Furin 1 | 0.0382 | 0.2286 | 0.2673 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.1372 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0777 | 0.5365 | 1 |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.0777 | 0.5365 | 0.6829 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0777 | 0.5365 | 1 |
Brugia malayi | proprotein convertase 2 | 0.0977 | 0.6921 | 0.6824 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Echinococcus granulosus | furin | 0.1372 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Loa Loa (eye worm) | hypothetical protein | 0.0619 | 0.413 | 0.3945 |
Brugia malayi | neuroendocrine convertase 1 precursor | 0.1132 | 0.8127 | 0.8068 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.1372 | 1 | 1 |
Trichomonas vaginalis | hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Schistosoma mansoni | subfamily S8B non-peptidase homologue (S08 family) | 0.0382 | 0.2286 | 0.2286 |
Brugia malayi | celfurPC protein | 0.1079 | 0.7714 | 0.7642 |
Loa Loa (eye worm) | hypothetical protein | 0.1372 | 1 | 1 |
Trichomonas vaginalis | leucine-rich repeat protein, BspA family | 0.0293 | 0.159 | 0.2963 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0977 | 0.6921 | 0.8929 |
Trichomonas vaginalis | proprotein convertase subtilisin/kexin type, putative | 0.0318 | 0.1781 | 0.3319 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0382 | 0.2286 | 0.426 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Trichomonas vaginalis | neuroendocrine convertase 2 precursor, putative | 0.0318 | 0.1781 | 0.3319 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0382 | 0.2286 | 0.426 |
Loa Loa (eye worm) | proprotein convertase 2 | 0.0382 | 0.2286 | 0.2043 |
Giardia lamblia | High cysteine membrane protein Group 2 | 0.0419 | 0.2574 | 1 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0977 | 0.6921 | 0.6824 |
Schistosoma mansoni | tyrosine kinase | 0.0128 | 0.0305 | 0.0305 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0293 | 0.159 | 0.2963 |
Schistosoma mansoni | furin-1 (S08 family) | 0.0659 | 0.4444 | 0.4444 |
Echinococcus granulosus | Furin 1 | 0.0382 | 0.2286 | 0.2043 |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.0777 | 0.5365 | 0.5219 |
Schistosoma mansoni | hypothetical protein | 0.0293 | 0.159 | 0.159 |
Loa Loa (eye worm) | hypothetical protein | 0.0179 | 0.0701 | 0.0409 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0382 | 0.2286 | 0.426 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.